Analysis of the preS1 gene of hepatitis B virus (HBV) to define epidemiologically linked and un-linked infections in South Africa

被引:13
|
作者
Hardie, DR [1 ]
Williamson, C [1 ]
机构
[1] S AFRICAN INST MED RES,CAPE TOWN,SOUTH AFRICA
关键词
D O I
10.1007/s007050050200
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Analysis of the preS1 gene of hepatitis B virus was used to define two nosocomial outbreaks of HBV infection. In an outbreak in an oncology unit we had previously shown by single stranded conformational polymorphism (SSCP) analysis of a 189 bp fragment of the preS1 gene, that 52 children were infected with HBV strains that displayed only 5 different SSCP profiles. Sequencing of a 383 bp fragment encompassing the entire preS1 gene, revealed that isolates with same SSCP profile were identical in sequence across the entire preS1 gene, confirming that those patients with the same SSCP pattern had epidemiologically linked infections. A second outbreak involved 8 liver transplant patients from two different hospitals, 5 of whom were from the same hospital at which the oncology outbreak had occurred. Two of these 5 patients had HBV strains that were identical to strains from the oncology unit and nosocomial transmission probably accounted for the infections in these two, while diversity of both SSCP profiles and sequence data of remaining 6 patients supported the conclusion that they had not been infected from a common source. The donor liver is believed to be the most likely source of infection in these patients. HBV isolates from patients infected in the community were used as a standard for the general degree of preS1 sequence variation of local HBV strains. Phylogenetic analysis and comparison with reference HBV clones revealed that of 27 local HBV strains, genotypes A and D occurred most frequently and were identified in 14 and 12 patients respectively, while genotype C was detected in one patient.
引用
收藏
页码:1829 / 1841
页数:13
相关论文
共 36 条
  • [31] Efficient control of hepatitis B virus replication is linked with strong HBV-specific immune reactivity and low number of mutations in HBV core gene immunodominant epitopes
    Carey, I.
    Mytilinaiou, M.
    Bansal, S.
    Meda, F.
    Longhi, M. S.
    Cebecaucrova, D.
    Mieli-Vergani, G.
    Vergani, D.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S208 - S208
  • [32] An antiviral drug-resistant mutant of hepatitis B virus with high replication capacity in association with a large in-frame deletion in the preS1 region of viral surface gene
    Wang, Ting
    Qin, Yanli
    Zhang, Jing
    Li, Xinyan
    Tong, Shuping
    Zhao, Weifeng
    Zhang, Jiming
    VIRUS GENES, 2020, 56 (06) : 677 - 686
  • [33] An antiviral drug-resistant mutant of hepatitis B virus with high replication capacity in association with a large in-frame deletion in the preS1 region of viral surface gene
    Ting Wang
    Yanli Qin
    Jing Zhang
    Xinyan Li
    Shuping Tong
    Weifeng Zhao
    Jiming Zhang
    Virus Genes, 2020, 56 : 677 - 686
  • [34] Phylogenetic analysis of the precore/core gene of hepatitis B virus genotypes E and A in West Africa:: new subtypes, mixed infections and recombinations
    Olinger, CM
    Venard, V
    Njayou, M
    Oyefolu, AOB
    Maïga, I
    Kemp, AJ
    Omilabu, SA
    le Faou, A
    Muller, CP
    JOURNAL OF GENERAL VIROLOGY, 2006, 87 : 1163 - 1173
  • [35] Deubiquitinase OTUD5 promotes hepatitis B virus replication by removing K48-linked ubiquitination of HBV core/precore and upregulates HNF4α expressions by inhibiting the ERK1/2/mitogen-activated protein kinase pathway
    Lou, Bin
    Ma, Guanghua
    Yu, Xiaopeng
    Lv, Feifei
    Xu, Fanjie
    Sun, Chengdi
    Chen, Yu
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2023, 80 (11)
  • [36] Deubiquitinase OTUD5 promotes hepatitis B virus replication by removing K48-linked ubiquitination of HBV core/precore and upregulates HNF4ɑ expressions by inhibiting the ERK1/2/mitogen-activated protein kinase pathway
    Bin Lou
    Guanghua Ma
    Xiaopeng Yu
    Feifei Lv
    Fanjie Xu
    Chengdi Sun
    Yu Chen
    Cellular and Molecular Life Sciences, 2023, 80